AKTX three-lens brief
Evidence-based stock research on AKTX. Three independent lenses — Foundation, Expansion, Climate — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Performance
Moved +4.49% yesterday. · Trading >3% below the 50-day MA — short-term weakness.
- Moved +4.49% yesterday.
- Trading >3% below the 50-day MA — short-term weakness.
- Underperforming SPY by 19.5pp over 30 days.
- Currently unprofitable on a trailing basis — no P/E multiple available.
- Analyst mean target $25.50 — 242% above current (3 analysts).
AKTX closed at $7.45 (+4.49%) as of 2026-11-12. Market cap: $17.02M. Price is below the 50-day MA and below the 200-day MA. Positives: moved +4.49% yesterday.; analyst mean target $25.50 — 242% above current (3 analysts).. Concerns: trading >3% below the 50-day MA — short-term weakness.; underperforming SPY by 19.5pp over 30 days.. Last quarter: net income -$4.81M, free cash flow -$9.38M. Watching for: 2026-11-12 earnings release (today).
Why three lenses on AKTX, not one.
A single reasoning model has blind spots it doesn’t know about. We examine AKTX across Foundation (fundamentals), Expansion (growth runway and market expansion), and Climate (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://www.clearpathinvest.app/embed/AKTX" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath AKTX brief"></iframe>